pe
pep-05267 v1 CC-BY-SA-4.0

Defensin alpha-4 anticancer peptide

A peptide studied in the lab for its ability to kill or slow the growth of cancer cells; experimental, not yet an approved drug.

statusbioassayed targetANTICANCER length52 aa refs3
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.486
avg pLDDT75.6
ranking score0.702
STRUCTURE · PEP-05267 × ANTICANCER
ranking0.702
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence52 aa
1510152025303540455052
MRTLAILAAILLF ALLAQAKSLQETA DDAATQEQPGEDD QDLAVSFEENGLS
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.7020208239555359 boltz-2
3-letter notation
Met-Arg-Thr-Leu-Ala-Ile-Leu-Ala-Ala-Ile-Leu-Leu-Phe-Ala-Leu-Leu-Ala-Gln-Ala-Lys-Ser-Leu-Gln-Glu-Thr-Ala-Asp-Asp-Ala-Ala-Thr-Gln-Glu-Gln-Pro-Gly-Glu-Asp-Asp-Gln-Asp-Leu-Ala-Val-Ser-Phe-Glu-Glu-Asn-Gly-Leu-Ser
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). Defensin alpha-4 anticancer peptide (pep-05267, v1). PeptideModel. https://peptidemodel.com/card/pep-05267
@peptide{pep05267,
  sequence = {MRTLAILAAILLFALLAQAKSLQETADDAATQEQPGEDDQDLAVSFEENGLS},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 5 by signal overlap
references 3 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use